New York, NY, United States of America

Attallah Kappas

This inventor holds 19 USPTO granted patents, plus 1 CIPO patent, primarily in Porphyrin Therapeutics. Top assignees: The Rockefeller University, Urecap Corporation. Active years: 1986-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Attallah Kappas. Retrieved from https://idiyas.com/inventor/attallah-kappas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.2

ph-index = 12

Forward Citations = 342(Granted Patents)


Location History:

  • Rye, NY (US) (1987)
  • New York, NY (US) (1986 - 1995)

Company Filing History:


Years Active: 1986-1995

Loading Chart...
Loading Chart...
Areas of Expertise:
Porphyrin Therapy
Iron Absorption
Endocrine Control
H. Pylori Treatment
Dermatitis Treatment
Cobalt Administration
Weight Control
Copper Excretion
Lipid Carriers
Heme Metabolism
Tryptophan Metabolism
Psoriasis Treatment
19 patents (USPTO):Explore Patents

Title: Innovation and Impact: The Contributions of Attallah Kappas

Introduction

Attallah Kappas, based in New York, NY, is a notable inventor and innovator known for her significant contributions to medical treatments. With a remarkable portfolio of 19 patents, Kappas has dedicated her career to advancing healthcare through innovative solutions.

Latest Patents

Among her latest patents, Kappas has developed a method and compositions for the treatment of H. pylori and dermatitis. This groundbreaking method involves orally administering a sufficient amount of a scavenging compound to eliminate bicarbonate ions, ammonium ions, or urea that coexist with harmful microorganisms in the gastrointestinal tract. These microorganisms are known to cause gastritis, gastric ulcers, and even pose a risk for gastric carcinoma. Additionally, Kappas has formulated a method that applies similar compounds to prevent or treat dermatitis, including diaper rash. Moreover, her patent for orally administered porphyrins aims to control intestinal iron absorption, highlighting her commitment to enhancing health and well-being.

Career Highlights

Throughout her career, Kappas has collaborated with esteemed institutions, including The Rockefeller University and Urecap Corporation. Her work with these organizations has allowed her to translate complex scientific knowledge into practical applications that benefit patients.

Collaborations

Kappas has had the privilege of working alongside distinguished colleagues such as George S. Drummond and Darryl Rideout. These collaborations have fostered an environment of innovation, enhancing the development of her patented methodologies.

Conclusion

Attallah Kappas exemplifies the spirit of innovation and dedication to improving human health. Her advancements in pharmaceutical compositions and treatment methods showcase her significant impact on the field. With 19 patents to her name, Kappas continues to inspire future generations of inventors striving to make a difference in the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…